SNCA and Parkinson disease: At follow-up, significantly decreased levels of CSF alpha-synuclein as compared to baseline were only seen in a subset of the patients (females with PD, prodromal PD patients specifically with dream-enactment behaviour, and healthy controls with daytime sleepiness).